VeriMomverbena officinalis callus lysate hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment specifically identifying reproductive hazard for Verbena officinalis callus lysate. No peer‑reviewed evidence of teratogenicity or developmental toxicity located in standard sources; plant cell culture lysates are generally complex mixtures without known reproductive toxicants for this species. Sources consulted: ECHA Annex VI (no harmonised entry), CosIng (ingredient listed as plant extract/lysate where present), PubChem/Chemical databases (no GHS reproductive hazard), PubMed (no reproductive toxicity studies identified).
Related ingredients
Frequently asked questions
- verbena officinalis callus lysate hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment specifically identifying reproductive hazard for Verbena officinalis callus lysate. No peer‑reviewed evidence of teratogenicity or developmental toxicity located in standard sources; plant cell culture lysates are generally complex mixtures without known reproductive toxicants for this species. Sources consulted: ECHA Annex VI (no harmonised entry), CosIng (ingredient listed as plant extract/lysate where present), PubChem/Chemical databases (no GHS reproductive hazard), PubMed (no reproductive toxicity studies identified).
- verbena officinalis callus lysate emzirirken güvenli mi?
- No data indicating mammary transfer or lactation-specific toxicity for Verbena officinalis callus lysate. No regulatory or peer‑reviewed reports raising concern; thus default to no evidence of hazard. Sources: PubMed (no relevant studies), ECHA/CosIng listings (no classification or warnings).
- verbena officinalis callus lysate bebek cildi için güvenli mi?
- No evidence of reproductive or developmental toxicity specific to infants. Hazard and mechanism default to 0 (no evidence). Exposure is set to 1 (low but measurable) for baby skin because topical plant extracts have potential for percutaneous absorption and infant skin has higher surface‑area‑to‑body‑weight and an immature barrier; adult exposure from cosmetic topical use is expected to be low. Sources: general dermal absorption principles, CosIng ingredient listing, lack of reproductive/toxicity data in PubMed/ECHA.
- VeriMom verbena officinalis callus lysate nasıl puanlıyor?
- VeriMom verbena officinalis callus lysate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte verbena officinalis callus lysate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.